7 articles
Index of editorial tags and filtered coverage.
Google DeepMind introduced SynthID Bio, a method that embeds an invisible signal into AI-designed proteins during the design process itself, aiming to strengthen biosecurity; in lab tests the watermarked proteins performed just as well as unmarked ones.
Reuters reported on 18–19 September 2026 that Anthropic runs a Bay Area wet lab; life-sciences head Eric Kauderer-Abrams confirms typical biotech work, Claude-directed robots with human oversight, and a focus on neglected diseases without running its own clinical trials for now.
TranscriptFormer/TF-Metazoa (Science, ~14 Sep 2026) trains a foundation model on ~112 million cells from 12 species to map cell types and states across organisms spanning ~1.5 billion years of evolution.
MutexaGPT (Nature Computational Science, 10 Sep 2026) orchestrates LLM agents to turn enzyme-engineering intuition into MD campaigns, with ~40% hit rate among prioritized cavity mutants.
QuantaMind (Science Advances, 14 Sep 2026) simulates complete catalytic cycles such as PETase at DFT-like accuracy, with enzyme and pH-antibody applications (~62× faster dissociation at pH 6).
Nature (Sep 9, 2026) presents ProteinTalks, a virtual cell built from more than 38 million temporal protein-abundance measurements on perturbed breast-cancer cell lines. It predicts drug efficacy/synergy, resistance proteins, and organoid/clinical transfer. DOI 10.1038/s41586-026-11001-9.
DeepMind practically solved much of protein folding in CASP14, with massive scientific impact.